Akademisyen
ELİF BİRTAŞ ATEŞOĞLU
PROFESÖR
YEDİTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 39
- Proje 0
- Kitap 1
- Bildiri 95
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
7
Q2
11
Q3
6
Q4
11
WoS (JCR)
Q1
1
Q2
7
Q3
12
Q4
15
TR Index
6
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
0
Ort. yüzdelik
77.5%
Üst %1 payı
0.0%
Üst %10 payı
0.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients YÖKSİS SJR Q2 JCR Q3
- 2025 T cell subgroup analysis and T cell exhaustion after autologous stem cell transplantation in lymphoma patients YÖKSİS SJR Q3 JCR Q4
- 2025 Tight competition for the first-line treatment of Hodgkin’s lymphoma: a comprehensive review of practice-changing developments in recent years YÖKSİS SJR Q1 JCR Q2
- 2025 Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Groups large B‐cell lymphoma cohort YÖKSİS SJR Q1 JCR Q2
- 2025 Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group YÖKSİS SJR Q2 JCR Q1
- 2025 A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies YÖKSİS TR Index SJR Q3 JCR Q3
- 2024 A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients YÖKSİS SJR Q2 JCR Q3
- 2023 Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data YÖKSİS SJR Q2 JCR Q2
- 2023 Comparative Efficacy and Safety of Beam and Team Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients YÖKSİS SJR Q3 JCR Q4
- 2021 Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid Leukemia YÖKSİS SJR Q4 JCR Q4
- 2017 IMMUNOSUPRESSIVE THERAPY IN A PATIENT WITH POSTPARTUM ACQUIRED HEMOPHILIA A: CASE PRESENTATION YÖKSİS
- 2016 Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms Angiopoietins do not only Regulate Tumor Angiogenesis YÖKSİS SJR Q4 JCR Q4
- 2016 Soluble Programmed Death 1 PD 1 Is Decreased in Patients With Immune Thrombocytopenia ITP YÖKSİS SJR Q2 JCR Q3 OpenAlex 81.3%
- 2016 Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts MDS RAEB2 YÖKSİS SJR Q4 JCR Q4
- 2016 Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation YÖKSİS SJR Q4 JCR Q4
- 2015 Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients YÖKSİS SJR Q2 JCR Q2
- 2015 The Role of Catenin in Bcr Abl Negative Myeloproliferative Neoplasms An Immunohistochemical Study YÖKSİS SJR Q2 JCR Q3
- 2015 Beta 2 microglobulin predicts the outcome after autologous stem cell transplantation in non Hodgkin lymphoma YÖKSİS SJR Q3 JCR Q4
- 2015 Treatment of patients with multiple myeloma over 65 yr more tolerability or better response YÖKSİS SJR Q1 JCR Q3 OpenAlex 72.0%
- 2015 Late onset Anticonvulsant Hypersensitivity Syndrome Mimicking Lymphoma YÖKSİS SJR Q3 JCR Q3